02005.HK 石四藥集團 | SSY GROUP | 公司資料 - 股權變動概覽 - etnet 經濟通|香港新聞財經資訊和生活平台

日期	股東名稱	披露原因	買入／賣出涉及的股份數目	每股平均價	持有權益的股份數目	佔已發行股本(%)
07/04/2025	China Pharmaceutical Company Limited	1710(L)	+6,000,000(L)	HKD3.006(L)	871,988,000(L)	29.52
07/04/2025	曲繼廣	1113(L)	+6,000,000(L)	HKD3.006(L)	1,162,626,000(L)	39.36
03/04/2025	China Pharmaceutical Company Limited	1710(L)	+3,000,000(L)	HKD3.355(L)	865,988,000(L)	29.31
03/04/2025	曲繼廣	1113(L)	+3,000,000(L)	HKD3.355(L)	1,156,626,000(L)	39.15
01/04/2025	China Pharmaceutical Company Limited	1710(L)	+3,000,000(L)	HKD3.363(L)	862,988,000(L)	29.22
01/04/2025	曲繼廣	1113(L)	+3,000,000(L)	HKD3.363(L)	1,152,226,000(L)	39.01
01/04/2025	曲繼廣	1101(L)	+1,400,000(L)	HKD3.374(L)	1,153,626,000(L)	39.05
31/03/2025	China Pharmaceutical Company Limited	1710(L)	+2,800,000(L)	HKD3.191(L)	859,988,000(L)	29.11
31/03/2025	曲繼廣	1113(L)	+2,800,000(L)	HKD3.191(L)	1,149,226,000(L)	38.90
21/02/2025	UBS Group AG	1201(L)	-372,000(L)	HKD3.244(L)	265,496,063(L)	8.98
20/02/2025	UBS Group AG	1101(L)	+198,000(L)	HKD3.335(L)	265,867,466(L)	9.00
18/02/2025	UBS Group AG	1201(L)	-448,204(L)	HKD3.238(L)	265,697,464(L)	8.99
08/01/2025	曲繼廣	1113(L)	+500,000(L)	HKD3.263(L)	1,146,426,000(L)	38.76
08/01/2025	China Pharmaceutical Company Limited	1710(L)	+500,000(L)	HKD3.263(L)	857,188,000(L)	28.98
07/01/2025	曲繼廣	1113(L)	+600,000(L)	HKD3.337(L)	1,145,926,000(L)	38.74
07/01/2025	China Pharmaceutical Company Limited	1710(L)	+600,000(L)	HKD3.337(L)	856,688,000(L)	28.96
06/01/2025	曲繼廣	1113(L)	+600,000(L)	HKD3.388(L)	1,145,326,000(L)	38.72
06/01/2025	China Pharmaceutical Company Limited	1710(L)	+600,000(L)	HKD3.388(L)	856,088,000(L)	28.94
03/01/2025	曲繼廣	1113(L)	+660,000(L)	HKD3.372(L)	1,144,726,000(L)	38.70
03/01/2025	China Pharmaceutical Company Limited	1710(L)	+660,000(L)	HKD3.372(L)	855,488,000(L)	28.92
26/11/2024	曲繼廣	1101(L)	+1,300,000(L)	HKD3.490(L)	1,144,066,000(L)	38.68
20/11/2024	曲繼廣	1101(L)	+400,000(L)	HKD3.880(L)	1,142,766,000(L)	38.63
19/11/2024	曲繼廣	1101(L)	+900,000(L)	HKD3.772(L)	1,142,366,000(L)	38.62
15/11/2024	China Pharmaceutical Company Limited	1710(L)	+1,000,000(L)	HKD3.807(L)	854,828,000(L)	28.90
15/11/2024	曲繼廣	1113(L)	+1,000,000(L)	HKD3.807(L)	1,141,466,000(L)	38.59
14/11/2024	China Pharmaceutical Company Limited	1710(L)	+1,000,000(L)	HKD3.817(L)	853,828,000(L)	28.87
14/11/2024	曲繼廣	1113(L)	+1,000,000(L)	HKD3.817(L)	1,140,466,000(L)	38.56
06/11/2024	UBS Group AG	1104(L)	+34,000(L)		295,795,721(L)	10.00
05/11/2024	UBS Group AG	1201(L)	-62,000(L)	HKD3.820(L)	295,775,721(L)	9.99
01/11/2024	UBS Group AG	1104(L)	+1,073,732(L)		296,837,530(L)	10.04
30/10/2024	China Pharmaceutical Company Limited	1710(L)	+780,000(L)	HKD3.718(L)	852,828,000(L)	28.83
30/10/2024	曲繼廣	1113(L)	+780,000(L)	HKD3.718(L)	1,139,466,000(L)	38.52
29/10/2024	曲繼廣	1113(L)	+1,280,000(L)	HKD3.753(L)	1,138,686,000(L)	38.50
29/10/2024	China Pharmaceutical Company Limited	1710(L)	+1,280,000(L)	HKD3.753(L)	852,048,000(L)	28.81
21/10/2024	曲繼廣	1113(L)	+800,000(L)	HKD3.898(L)	1,137,406,000(L)	38.45
21/10/2024	China Pharmaceutical Company Limited	1710(L)	+800,000(L)	HKD3.898(L)	850,768,000(L)	28.76
17/10/2024	UBS Group AG	1205(L)	-300,000(L)		295,665,644(L)	9.99
16/10/2024	UBS Group AG	1104(L)	+980,000(L)		296,385,646(L)	10.02
14/10/2024	曲繼廣	1113(L)	+1,000,000(L)	HKD4.137(L)	1,136,606,000(L)	38.42
14/10/2024	China Pharmaceutical Company Limited	1710(L)	+1,000,000(L)	HKD4.137(L)	849,968,000(L)	28.73

1 2 3

備註：	(L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
	(S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
	(P) - 可供借出的股份
	即時報價更新時間為 09/04/2025 17:59
	港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站